Today: 22 May 2026
Broadcom stock price jumps nearly 4% as Google’s AI capex plan lifts AVGO

Broadcom stock price jumps nearly 4% as Google’s AI capex plan lifts AVGO

New York, Feb 6, 2026, 10:21 a.m. EST — Market open for regular trading.

  • Broadcom shares climbed roughly 4% in morning trading amid a wider bounce in chip stocks.
  • Alphabet’s massive spending forecast for 2026 has shifted the spotlight back onto AI infrastructure suppliers.
  • Investors are turning to Broadcom’s March 4 earnings for fresh insights on demand.

Shares of Broadcom Inc (AVGO.O) jumped almost 4% on Friday, hitting $322.82 in morning trading. Investors appeared to come back to AI-related chip stocks following a tough week for the tech sector.

Alphabet’s forecast points to capital expenditure hitting between $175 billion and $185 billion in 2026, covering investments in servers, data centers, and more. “Our AI investments and infrastructure are fueling revenue and growth across the board,” CEO Sundar Pichai told analysts. Reuters

Why it matters now: investors wrestle with soaring AI budgets while worrying profits might not keep pace. Big Tech’s planned $600 billion AI spending spree this year has rattled software and data stocks, which tumbled on worries about disruption. Traders are growing increasingly alert to signs that margins could take a hit.

Broadcom stands to benefit clearly. The company, which makes networking chips and custom processors called ASICs — application-specific integrated circuits — sees a direct impact. Jefferies analyst Blayne Curtis noted that Google’s increased capital expenditure “offers a significant vote of confidence for AI spend moving higher.” MarketWatch

The chip sector lit up Tuesday. Nvidia climbed around 4.7%, AMD jumped close to 6.1%, and Marvell gained just under 5%. Alphabet slipped about 2.8%, dragged down by investor concerns over the bill’s scale.

The iShares Semiconductor ETF jumped roughly 3.3% in early trade, mirroring a wider rebound among chipmakers.

The rebound follows a sharp sell-off that spilled far outside software. Reuters’ Morning Bid highlighted how AI fears have erased nearly $1 trillion from software stocks in just one week, with AMD among the steepest decliners during the turmoil.

Yet those spending plans, which boost suppliers, now pose a new risk. Amazon’s $200 billion capital budget for 2026 has reignited dot-com era echoes. MoffettNathanson pointed out that “the magnitude of the spend is materially greater than consensus expected,” setting the stage for potential letdowns. Reuters

Kristina Hooper, chief market strategist at Man Group, noted the market is shifting from “unabashed enthusiasm” to “a period of greater discernment.” This change is already reflected in how investors view hefty AI capital expenditure plans. Reuters

Jefferies stuck with its “top pick” rating on Broadcom and maintained a $500 price target, Investor’s Business Daily reported. The firm highlighted increased cloud spending on custom silicon as a key driver behind the bullish outlook. Investors

Broadcom’s Q1 earnings report on March 4 will be a key moment, as investors look for shifts in demand from its biggest clients and updates on AI infrastructure purchases. The company plans to hold its earnings call at 5:00 p.m. ET.

Stock Market Today

  • Q1 Earnings Review: Azenta Falls; West Pharmaceutical Leads Drug Development Services Stocks
    May 21, 2026, 9:31 PM EDT. Drug development inputs and services stocks, essential for pharmaceutical research and manufacturing, reported mixed Q1 results. Azenta (NASDAQ:AZTA), specializing in biological sample management, posted disappointing results with $144.8 million revenue, missing estimates and the weakest among peers, causing its share price to drop 23.4% to $17.65. Conversely, West Pharmaceutical Services (NYSE:WST), maker of specialized packaging and delivery devices, delivered a strong quarter with $844.9 million revenue, beating estimates by 8.4%. Overall, the sector's revenues beat consensus by 1.6%, despite an average 2.5% share price decline post-earnings. Tailwinds include growth in biologics and gene therapies, while headwinds feature pricing pressure and regulatory risks.

Latest articles

OpenAI Shares Hype Returns, Still No Ticker in Sight

OpenAI Shares Hype Returns, Still No Ticker in Sight

22 May 2026
OpenAI is preparing to confidentially file for a U.S. IPO, aiming to go public as early as September, sources told Reuters. The move follows a court win against Elon Musk, removing a key legal obstacle. Private-market share prices for OpenAI ranged from $658.94 to $732.38 this month, but no official public price exists. Ordinary investors still cannot buy OpenAI stock on public exchanges.
Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

22 May 2026
Estée Lauder and Spain’s Puig ended merger talks that would have created a $40 billion beauty group. Estée Lauder shares rose about 10% in after-hours trading, closing the regular session at $78.91. The company said it will focus on its turnaround plan and continue reviewing possible acquisitions or divestitures.
WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

22 May 2026
WhiteFiber shares jumped 22.2% to $29.55 after announcing a five-year AI compute contract worth over $160 million for a Paris-region deployment using NVIDIA GPU systems. Google Finance showed the stock rising further after hours. The project is backed by planned financing and 12 months of customer prepayments, but funding and execution remain pending. Service is expected to start in July, subject to equipment delivery and acceptance.
Google stock price slips as Alphabet’s AI spending push keeps GOOG in focus
Previous Story

Google stock price slips as Alphabet’s AI spending push keeps GOOG in focus

Robinhood stock jumps nearly 15% as bitcoin rebounds; earnings next week in focus
Next Story

Robinhood stock jumps nearly 15% as bitcoin rebounds; earnings next week in focus

Go toTop